IDXX(IDEXX Laboratories, Inc.) 的财务报表:医疗保健,诊断与研究。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $3.22B | $3.37B | $3.66B | $3.90B | $4.30B |
| 毛利润 | $1.89B | $2.00B | $2.19B | $2.38B | $2.66B |
| 营业利润 | $932.03M | $898.76M | $1.10B | $1.13B | $1.36B |
| 净利润 | $744.85M | $679.09M | $845.04M | $887.87M | $1.06B |
| 经营现金流 | $755.55M | $542.98M | $906.51M | $929.00M | $1.18B |
| 自由现金流 | $636.00M | $394.15M | $772.88M | $808.08M | $1.06B |
| 摊薄每股收益 | $8.60 | $8.03 | $10.06 | $10.67 | $13.08 |